CFH and Alzheimer disease: Clinical data from human AD brains indicate that miR-125b and miR-146 levels are elevated to aggravate neuroinflammation and reduce complement factor H, which is associated with the neuronal release of mR-146a and miR-155 and inflammatory spreading in the AD brain (65, 66).